---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-26-000025"
form_type: "8-K/A"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2026-06-30T10:01:12+00:00"
generated_at: "2026-06-30T10:10:58.086967+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Acquired OTC Wellness Business Q1 net sales $51.7M, net income $12.6M

## Summary
- Net sales of $51.7M for Q1 2026, up 2.4% from $50.5M in Q1 2025.
- Net income of $12.6M, down 14.4% from $14.8M in prior-year quarter.
- Intangible assets net of $328.3M and goodwill of $151.5M as of March 31, 2026.
- Business includes brands Breathe Right, Dimetapp, Anbesol, Alavert, Primatene, and others.
- Pro forma financials for Prestige Consumer Healthcare also filed as part of the acquisition.

## SEC filing metadata
- accession: 0001295947-26-000025
- form_type: 8-K/A
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2026-06-30T10:01:12+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000025/0001295947-26-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000025/pbh-20260612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-26-000025
- JSON: https://secwatch.observer/filing/0001295947-26-000025.json
- Plain text: https://secwatch.observer/filing/0001295947-26-000025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.